Wall stress-induced arrhythmias in the working rat heart as left ventricular hypertrophy regresses during captopril treatment

Cardiovascular Research

Volumn 33, Issue 3, 1997, Pages 561-572

  Dalton, Geoff R ^a,b   Jones, John V ^b   Evans, Stephen J ^b   Levi, Allan J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

ACE inhibitors; Arrhythmias; Hypertrophy; Rat, spontaneously hypertensive; Regression; Wall stress

Indexed keywords

CAPTOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE WALL; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ARRHYTHMIA; CAPTOPRIL; HEART; HYPERTROPHY, LEFT VENTRICULAR; MALE; PERFUSION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; TIME FACTORS;

EID: 0031052572     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00242-8     Document Type: Article

References (39)

1. Messerli FH, Ventura HO, Elizardi DJ, et al. Hypertension and sudden death increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med 1984;77:18-22.
2. Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med 1983;75:4-11.
3. McLenachan JM, Dargie HJ. Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis. Am J Hypertens 1990;3:735-740.
4. Vogt M, Motz W, Scheler S, Strauer BE. Disorders of coronary microcirculation and arrhythmias in systemic arterial hypertension. Am J Cardiol 1990;65:45G-50G.
5. Messerli FH, Grodzicki T. Hypertension, left ventricular hypertrophy, ventricular arrhythmias and sudden death. Eur Heart J 1992;13:66-69.
6. Saragoca MA, Cassiolatto JL, Vanetta AM, et al. Reversal of left ventricular hypertrophy with isradipine diminution of cardiac arrhythmias. Am J Hypertens 1993;6:89S-91S.
7. Gonzalez-Fernandez RA, Rivera M, Rodriguez PJ, et al. Prevalence of ectopic ventricular activity after left ventricular mass regression. Am J Hypertens 1993;6:308-313.
8. Natsume T, Kardon MB, Pegram BL, Frohlich ED. Ventricular performance in spontaneously hypertensive rats (SHR) with reduced cardiac mass. Cardiovasc Drugs Ther 1989;3:433-439.
9. Kuzuo H, Honda M, Ishinaga Y, et al. Angiotensin converting enzyme inhibitor, captopril, inhibits cardiac hypertrophy without changing collagen types and concentration in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1993;20:253-260.
10. Pfeffer JM, Pfeffer MA, Mirsky I, Braunwald E. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. Proc Natl Acad Sci USA 1982;79:3310-3314.
11. Pahor M, Bernabei R, Sgadari A, et al. Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats. Hypertension 1991;18:148-157.
12. Trippodo NC, Frohlich ED. Similarities of genetic (spontaneous) hypertension: man and rat. Circ Res 1981;48:309-319.
13. Sasaki O, Frohlich ED. The spontaneously hypertensive rat as a model for human essential hypertension. In: Aoki K, Frohlich ED, eds. Calcium in Essential Hypertension. Tokyo: Academic Press, 1989:456-469.
14. James MA, Jones JV. Systolic wall stress and ventricular arrhythmia: The role of acute change in blood pressure in the isolated working rat heart. Clin Sci 1990;79:499-504.
15. Evans SJ, Levi AJ, Jones JV. Wall-Stress induced arrhythmia is enhanced by low potassium and early LVH in the working rat heart. Cardiovasc Res 1995;29:555-562.
16. James MA, Jones JV. Ventricular arrhythmia in untreated newly presenting hypertensive patients compared with a matched normal population. J Hypertens 1989;7:409-415.
17. Kannel WB, Dawber TR. Hypertensive cardiovascular disease: The Framingham heart study. In: Onesti G, Kim KE, Maya JH, eds. Hypertension: Mechanisms and Management. New York: Grune and Stratton, 1973:93-114.
18. Sideris DA, Kontoyannis DA, Michails L, et al. Acute changes in blood pressure as a cause of cardiac arrhythmias. Eur Heart J 1987;8:45-52.
19. Taggart P, Sutton P, Lab MJ, Runnalls M, OBrien W, Treasure T. Effect of abrupt changes in ventricular loading on repolarization induced by transient aortic occlusion in humans. Am J Physiol Heart Circ Physiol 1992;263:H816-H823.
20. Lab MJ. Contraction-excitation feedback in myocardium. Physiological basis and clinicl relevance. Circ Res 1982;50:757-766.
21. Reiter MJ, Synhorst DP, Mann DE. Electrophysiological effects of acute ventricular dilatation in the isolated rabbit heart. Circ Res 1988;62:554-562.
22. Neely J, Leibermeister H, Battersby E, Morgan H. Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol 1967;212:804-814.
23. Taegtmeyer H, Hems R, Krebs H. Utilisation of energy-providing substrates in the isolated working rat heart. Biochem J 1980;186:701-711.
24. Suga H, Sagawa K. Instantaneous pressure-volume relationships and their ratio in the excised, supported canine left ventricle. Circ Res 1974;35:117-126.
25. Besse P. Indices of function: invasive exploratory methods. In: Swynghedauw B, ed. Cardiac hypertrophy and failure. London: John Libbey, 1990:325-351.
26. Hansen DE, Borganelli M, Stacy GP, Jr, Taylor LK. Dose-dependent inhibition of stretch-induced arrhythmias by gadolinium in isolated canine ventricles. Circ Res 1991;69:820-831.
27. Evans SJ, Levi AJ, Lee JA, Jones JV. EMD 57033 enhances arrhythmias associated with increased wall-stress in the working rat heart. Clin Sci 1995;89:59-67.
28. Evans SJ, Levi AJ, Jones JV. Potassium depletion enhances wall-stress induced arrhythmias in the spontaneously hypertensive rat heart. J Physiol 1994;47.P:54P (Abstract)
29. Walker MJA, Curtis MJ, Hearse DJ, et al. The Lambeth Conventions: Guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 1988;22:447-455.
30. Dodge HT, Sandler H. Clinical applications of angiocardiography. In: Mirsky I, Gista DN, Sandler H, eds. Cardiac Mechanics: Physiological, Clinical, and Mathematical Considerations. New York: John Wiley, 1974:171-201.
31. Litwin SE, Katz SE, Weinberg EO, Lorell BH, Aurigemma GP, Douglas PS. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy: Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation 1995:91:2642-2654.
32. Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens 1991;9:3-15.
33. Kohya T, Yokoshiki H, Tohse N, et al. Regression of left ventricular hypertrophy prevents ischemia-induced lethal arrhythmias: Beneficial effect of angiotensin II blockade. Circ Res 1995;76:892-899.
34. Van Gilst WH, De Graeff PA, Wesseling H, De Langen CDJ. Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotension converting enzyme inhibitors: A comparison of captopril, enalapril, and HOE 498. J Cardiovasc Pharmacol 1986;8:722-728.
35. Fleetwood G, Boutinet S, Meier M, Wood JM. Involvement of the renin-angiotensin system in ischemic damage and reperfusion arrhythmias in the isolated perfused rat heart. J Cardiovasc Pharmacol 1991;17:351-356.
36. Scholkens BA, Linz W. Cardioprotective effects of ACE inhibitors: Experimental proof and clinical perspectives. Clin Physiol Biochem 1990;8:33-43.
37. Rials SJ, Wu Y, Ford N, et al. Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart. Circulation 1994;91:426-430.
38. Subha S, Tarazi RC, Merlin Bumpus F. Biochemical changes associated with development and reversal of cardiac hypertrophy in spontaneously hypertensive rats. Cardiovasc Res 1976;10:254-261.
39. Villari B, Vassalli G, Monrad S, Chiariello M, Turina M, Hess O. Normalization of diatolic dysfunction in aortic stenosis late after valve replacement. Circulation 1995;91:2353-2358.